Last reviewed · How we verify
NCT03423524: PHY1801
Clinical Study to Investigate Visual Performance of a Hydrophobic Monofocal IOL After Bilateral Implantation
NA trial testing Micropure 1.2.3. in Cataract in 20 participants. Completed in 27 July 2021.
27 July 2021
Quick facts
| Lead sponsor | Beaver-Visitec International, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 2 May 2018 |
| Primary completion | 27 July 2021 |
| Estimated completion | 27 July 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Micropure 1.2.3.
Conditions studied
- Cataract — all drugs for Cataract →
- Lens Opacities — all drugs for Lens Opacities →
Sponsor
Beaver-Visitec International, Inc.
Who can join
45 and older, any sex, with Cataract or Lens Opacities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective, non-randomised, open, controlled, single-center post-market clinical follow study about Micropure 1.2.3 IOL.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03423524
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Micropure 1.2.3.
Trials testing the same drug.
- NCT03796624 — Clinical Outcomes of MICROPURE and PodEye Monofocal Intraocular Lenses · NA · completed
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Beaver-Visitec International, Inc. trials
Trials by the same sponsor.
- NCT05875922 — Comparison of ISOPURE and EYHANCE (Switzerland) · NA · completed
- NCT04176965 — Investigation of the Safety and Effectiveness of a Trifocal IOL · NA · completed
- NCT05235139 — PMCF Study on Comparison of EDOF Lenses (Switzerland) · NA · completed
- NCT05255029 — Clinical Investigation of a Monofocal Toric Intra Ocular Lens (IOL) in Cataractous Eyes · NA · completed
- NCT04987216 — PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Europe (PHY2104) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03423524 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beaver-Visitec International, Inc.
- Last refreshed: 15 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03423524.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing